| Literature DB >> 15131310 |
Robert J Harvey1, Ulrike B Depner, Heinz Wässle, Seifollah Ahmadi, Cornelia Heindl, Heiko Reinold, Trevor G Smart, Kirsten Harvey, Burkhard Schütz, Osama M Abo-Salem, Andreas Zimmer, Pierrick Poisbeau, Hans Welzl, David P Wolfer, Heinrich Betz, Hanns Ulrich Zeilhofer, Ulrike Müller.
Abstract
Prostaglandin E2 (PGE2) is a crucial mediator of inflammatory pain sensitization. Here, we demonstrate that inhibition of a specific glycine receptor subtype (GlyR alpha3) by PGE2-induced receptor phosphorylation underlies central inflammatory pain sensitization. We show that GlyR alpha3 is distinctly expressed in superficial layers of the spinal cord dorsal horn. Mice deficient in GlyR alpha3 not only lack the inhibition of glycinergic neurotransmission by PGE2 seen in wild-type mice but also show a reduction in pain sensitization induced by spinal PGE2 injection or peripheral inflammation. Thus, GlyR alpha3 may provide a previously unrecognized molecular target in pain therapy.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15131310 DOI: 10.1126/science.1094925
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728